Browse > Article

Human Apolipoprotein E2 Transgenic Mice Show Lipid Accumulation in Retinal Pigment Epithelium and Altered Expression of VEGF and bFGF in the Eyes  

Lee, Sung-Joon (Division of Food Bioscience and Technology, College of Life Sciences and Biotechnology, Institute of Biomedical Science and Safety, Korea University)
Kim, Jeong-Hun (Department of Ophthalmology, College of Medicine, Seoul National University & Clinical Research Institute, Seoul National University Hospital)
Kim, Jin-Hyoung (Division of Pharmaceutical Bioscience, College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University)
Chung, Mi-Ja (Division of Food Bioscience and Technology, College of Life Sciences and Biotechnology, Institute of Biomedical Science and Safety, Korea University)
Wen, Qingcheng (Division of Food Bioscience and Technology, College of Life Sciences and Biotechnology, Institute of Biomedical Science and Safety, Korea University)
Chung, Hum (Department of Ophthalmology, College of Medicine, Seoul National University & Clinical Research Institute, Seoul National University Hospital)
Kim, Kyu-Won (Division of Pharmaceutical Bioscience, College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University)
Yu, Young-Suk (Department of Ophthalmology, College of Medicine, Seoul National University & Clinical Research Institute, Seoul National University Hospital)
Publication Information
Journal of Microbiology and Biotechnology / v.17, no.6, 2007 , pp. 1024-1030 More about this Journal
Abstract
We investigated the human apolipoprotein E2 (apoE2) transgenic mouse as an animal model system for age-related macular degeneration (AMD). Transgenic mice expressing human apoE2 and C57BL/6J mice were fed normal chow or a high-fat diet for 4 weeks. Eyes were collected from the mice and lipid deposits in retinal pigment epithelium (RPE) were assessed using electron microscopy. The expressions of apoE, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and pigment-epithelium derived factor (PEDF), which are molecular markers for angiogenesis, were assessed with immunohistochemistry. Eyes from apoE2 mice, regardless of diet, contained lipid accumulation in RPE under electron microscopy, whereas control C57BL/6J eyes did not. Lipid accumulation was found predominantly in the RPE and the Bruch's membrane and increased in the eyes of apoE2 mice after one month of a high-fat diet ($8{\pm}2\;per\;50{\mu}m^2$ for normal chow and $11{\pm}2\;per\;50\;{\mu}m^2,\;p<0.05)$. ApoE expression was similar in the apoE2 and control mice; however, VEGF and bFGF were overexpressed in the retinal pigment epithelium of apoE2 eyes compared with control eyes, and PEDF expression was slightly decreased. These expression patterns of VEGF, bFGF, and PEDF suggest angiogenesis is progressing in apoE2 eyes. In conclusion, the eyes of apoE2 mice develop typical lipid accumulations, a common characteristic of AMD, making them a suitable animal model for AMD. The expression profile of VEGF and bFGF on the retinal pigment epithelium suggests that apoE2 may induce neovascularization by altering angiogenic cytokines.
Keywords
Age-related macular degeneration; apolipoprotein E2; VEGF; bFGF;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 13  (Related Records In Web of Science)
연도 인용수 순위
1 Bhutto, I. A., D. S. McLeod, T. Hasegawa, S. Y. Kim, C. Merges, P. Tong, and G. A. Lutty. 2006. Pigment epitheliumderived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with agerelated macular degeneration. Exp. Eye Res. 82: 99-110   DOI   ScienceOn
2 De Jong, P. T. 2004. Risk profiles for ageing macular disease. Ophthalmologica 218 Suppl 1: 5-16; discussion 39-41   DOI   ScienceOn
3 Gehlbach, P., A. M. Demetriades, S. Yamamoto, T. Deering, E. J. Duh, H. S. Yang, C. Cingolani, H. Lai, L. Wei, and P. A. Campochiaro. 2003. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther. 10: 637-646   DOI   ScienceOn
4 Howes, K. A., J. M. Frederick, A. Marks, and W. Baehr. 2003. Progressive pathways in age-related macular degeneration. Adv. Exp. Med. Biol. 533: 91-96
5 Kim, S.-J., D. Y. Jun, C. H. Yang, and Y. H. Kim. 2006. Cloning and expression of hpaA gene of Korean strain Helicobacter pylori K51 in oral vaccine delivery vehicle Lactococcus lactis subsp. lactis MG1363. J. Microbiol. Biotechnol. 16: 318-324   과학기술학회마을
6 Ko, H.-R., H. Kakeya, A. Yoshida, R. Onose, M. Ueki, M. Muroi, A. Takatsuki, H. Matsuzaki, and H. Osada. 2002. PC- 766B' and PC 766B, 16-membered macrolide angiogenesis inhibitors produced by Nocardia sp. RK-97-56. J. Microbiol. Biotechnol. 12: 829-833
7 Lee, S. J., S. Kadambi, K. C. Yu, C. David, S. Azhar, A. D. Cooper, and S. Y. Choi. 2005. Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase. J. Lipid Res. 46: 27-35   DOI   ScienceOn
8 Malek, G., C. M. Li, C. Guidry, N. E. Medeiros, and C. A. Curcio. 2003. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am. J. Pathol. 162: 413-425   DOI   ScienceOn
9 Scrofani, S. D. B. and A. D. Nash. 2001. Toward a structurefunction relationship for vascular endothelial growth factor- B (VEGF-B). J. Microbiol. Biotechnol. 11: 543-551
10 Weisgraber, K. H., T. L. Innerarity, and R. W. Mahley. 1982. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257: 2518-2521
11 Yamamura, T., L. M. Dong, and A. Yamamoto. 1992. Apolipoprotein E polymorphism and coronary heart disease. Chin. Med. J. (Engl) 105: 738-741
12 Lim, J. K., H. J. Seo, E. O. Kim, M. Meydani, and J. D. Kim. 2006. Identification of anti-angiogenic and anti-cell adhesion materials from halophilic enterobacteria of the Trachurus japonicus. J. Microbiol. Biotechnol. 16: 1544-1553   과학기술학회마을
13 Browning, A. C., W. M. Amoaku, and H. S. Dua. 2004. Treatment of age-related macular degeneration. J. Soc. Med. 97: 166-169   DOI   ScienceOn
14 Amano, S., S. Yamagishi, Y. Inagaki, K. Nakamura, M. Takeuchi, H. Inoue, and T. Imaizumi. 2005. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvasc. Res. 69: 45-55   DOI   ScienceOn
15 Simonelli, F., M. Margaglione, F. Testa, G. Cappucci, M. P. Manitto, R. Brancato, and E. Rinaldi. 2001. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res. 33: 325-328   DOI   ScienceOn
16 Dawson, D. W., O. V. Volpert, P. Gillis, S. E. Crawford, H. Xu, W. Benedict, and N. P. Bouck. 1999. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 285: 245-248   DOI   ScienceOn
17 Hageman, G. S., P. J. Luthert, N. H. Victor Chong, L. V. Johnson, D. H. Anderson, and R. F. Mullins. 2001. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20: 705-732   DOI   ScienceOn
18 Duh, E. J., H. S. Yang, I. Suzuma, M. Miyagi, E. Youngman, K. Mori, M. Katai, L. Yan, K. Suzuma, K. West, S. Davarya, P. Tong, P. Gehlbach, J. Pearlman, J. W. Crabb, L. P. Aiello, P. A. Campochiaro, and D. J. Zack. 2002. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 43: 821-829
19 Kliffen, M., E. Lutgens, M. J. Daemen, E. D. de Muinck, C. M. Mooy, and P. T. de Jong. 2000. The APO($^{\ast}$)E3-Leiden mouse as an animal model for basal laminar deposit. Br. J. Ophthalmol. 84: 1415-1419   DOI   ScienceOn
20 Algvere, P. V. and S. Seregard. 2003. Drusen maculopathy: A risk factor for AMD. Can we prevent visual loss? Acta Ophthalmol. Scand. 81: 427-429   DOI   ScienceOn
21 Ogata, N., A. Ando, M. Uyama, and M. Matsumura. 2001. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefe's Arch. Clin. Exp. Ophthalmol. 239: 87-95   DOI   ScienceOn
22 Hera, R., M. Keramidas, M. Peoc'h, M. Mouillon, J. P. Romanet, and J. J. Feige. 2005. Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration. Am. J. Ophthalmol. 139: 589-596   DOI   ScienceOn
23 Werdich, X. Q., G. W. McCollum, V. S. Rajaratnam, and J. S. Penn. 2004. Variable oxygen and retinal VEGF levels: Correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy. Exp. Eye Res. 79: 623-630   DOI   ScienceOn
24 Mori, K., P. Gehlbach, A. Ando, D. McVey, L. Wei, and P. A. Campochiaro. 2002. Regression of ocular neovascularization in response to increased expression of pigment epitheliumderived factor. Invest. Ophthalmol. Vis. Sci. 43: 2428-2434
25 Mori, K., E. Duh, P. Gehlbach, A. Ando, K. Takahashi, J. Pearlman, K. Mori, H. S. Yang, D. J. Zack, D. Ettyreddy, D. E. Brough, L. L. Wei, and P. A. Campochiaro. 2001. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J. Cell Physiol. 188: 253-263   DOI   ScienceOn
26 Kopitz, J., F. G. Holz, E. Kaemmerer, and F. Schutt. 2004. Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie 86: 825-831   DOI   ScienceOn
27 Presta, M., P. Dell'Era, S. Mitola, E. Moroni, R. Ronca, and M. Rusnati. 2005. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16: 159-178   DOI   ScienceOn
28 Havekes, L., E. de Wit, J. G. Leuven, E. Klasen, G. Utermann, W. Weber, and U. Beisiegel. 1986. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum. Genet. 73: 157-163   DOI
29 Kang, K. Y., C. H. Choi, J. Y. Oh, H. Kim, G. R. Kweon, and J. C. Lee. 2005. Chloramphenicol arrests transition of cell cycle and induces apoptotic cell death in myelogenous leukemia cells. J. Microbiol. Biotechnol. 15: 913-918
30 Mullins, R. F., S. R. Russell, D. H. Anderson, and G. S. Hageman. 2000. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14: 835-846   DOI
31 Klein, R., T. Peto, A. Bird, and M. R. Vannewkirk. 2004. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 137: 486-495   DOI   ScienceOn
32 de Knijff, P., A. M. van den Maagdenberg, A. F. Stalenhoef, J. A. Leuven, P. N. Demacker, L. P. Kuyt, R. R. Frants, and L. M. Havekes. 1991. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. J. Clin. Invest. 88: 643-655   DOI
33 de Man, F. H., F. de Beer, A. van de Laarse, A. H. Smelt, J. A. Leuven, and L. M. Havekes. 1998. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase. Atherosclerosis 136: 255-262   DOI   ScienceOn
34 Kliffen, M., H. S. Sharma, C. M. Mooy, S. Kerkvliet, and P. T. de Jong. 1997. Increased expression of angiogenic growth factors in age-related maculopathy. Br. J. Ophthalmol. 81: 154-162   DOI   ScienceOn
35 Badimon, J. J., B. A. Kottke, T. C. Chen, L. Chan, and S. J. Mao. 1986. Quantification and immunolocalization of apolipoprotein E in experimental atherosclerosis. Atherosclerosis 61: 57-66   DOI   ScienceOn
36 Mahley, R. W., Y. Huang, and S. C. Rall Jr. 1999. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J. Lipid Res. 40: 1933-1949
37 Klaver, C. C., M. Kliffen, C. M. van Duijn, A. Hofman, M. Cruts, D. E. Grobbee, C. van Broeckhoven, and P. T. de Jong. 1998. Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet. 63: 200-206   DOI   ScienceOn
38 Rudolf, M., B. Ivandic, J. Winkler, and U. Schmidt-Erfurth. 2004. Accumulation of lipid particles in Bruch's membrane of LDL receptor knockout mice as a model of age-related macular degeneration. Ophthalmologe 101: 715-719
39 Schmidt, S., C. Klaver, A. Saunders, E. Postel, M. De La Paz, A. Agarwal, K. Small, N. Udar, J. Ong, M. Chalukya, A. Nesburn, C. Kenney, R. Domurath, M. Hogan, T. Mah, Y. Conley, R. Ferrell, D. Weeks, P. T. de Jong, C. van Duijn, J. Haines, M. Pericak-Vance, and M. Gorin. 2002. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet. 23: 209-223   DOI   ScienceOn
40 Cooper, A. D. 1997. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38: 2173-2192
41 Sullivan, P. M., H. Mezdour, S. H. Quarfordt, and N. Maeda. 1998. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe$^{\ast}$2. J. Clin. Invest. 102: 130-135   DOI   ScienceOn
42 Pola, R., E. Gaetani, A. Flex, T. Aprahamian, A. S. Proia, M. Bosch-Marce, R. C. Smith, and P. Pola. 2003. Peripheral nerve ischemia: Apolipoprotein E deficiency results in impaired functional recovery and reduction of associated intraneural angiogenic response. Exp. Neurol. 184: 264-273   DOI   ScienceOn